Ahmed Ibrahim Abdeltawwab Hussein

Dr. Ahmed Ibrahim Abdeltawwab Hussein

Faculty of Pharmacy, Asian Institute of Medicine, Science and Technology, Bedong, Malaysia
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2025 in Current Trends in Biotechnology and Pharmacy
Verified
Journal Article
Open access
PDF file
Ahmed Ibrahim Abdeltawwab HusseinAhmed Ibrahim Abdeltawwab Hussein
Ahmed Ibrahim Abdeltawwab Hussein
RHRosnani Hashim
Rosnani Hashim
ZZZainol Akbar Zainal
Zainol Akbar Zainal
SHShairyzah Ahmad Hisham
Shairyzah Ahmad Hisham
SASyamhanin Adnan
Syamhanin Adnan
NNNoorlina Binti Nordin
Noorlina Binti Nordin
Even though highly active antiretroviral therapy (HAART) is successful in decreasing HIV-related illness and death, concerns about metabolic syndrome (MetS) are increasing. However, there is limited evidence on the predictors of MetS among adults undergoing first-line HAART regimens in Malaysia. This study aimed to compare the MetS components between first-line HAART regimens containing integrase strand transfer inhibitor (INSTI) and non-INSTI regimens at baseline and 12-month follow-up. Additionally, it aimed to identify predictors of MetS among HIV patients on first-line HAART. This prospective cohort study included adults diagnosed with HIV from January 2023 till April 2023 and receiving first-line HAART for a minimum of 6 months, undergoing follow-up at Hospital Sungai Buloh, Malaysia. Data from 210 patients, mostly males (91.9%) and Malays (47.1%), were analyzed. Significant mean differences in MetS components were observed between patients receiving INSTI and non-INSTI regimens. Multivariate binary logistic regression analysis identified depressive disorders, non-INSTI HAART regimens, and age as significant predictors of MetS among HIV patients. The incidence of MetS was considerable among the study population, highlighting the significance of routinely monitoring patients' clinical and laboratory data and promoting health education to effectively manage and avoid HIV patients' metabolic illnesses.

1 April 2024 in Universal Journal of Public Health
Verified
Journal Article
Open access
PDF file
Ahmed Ibrahim Abdeltawwab HusseinAhmed Ibrahim Abdeltawwab Hussein
Ahmed Ibrahim Abdeltawwab Hussein
RHRosnani Hashim
Rosnani Hashim
ZZZainol Akbar Zainal
Zainol Akbar Zainal
SHShairyzah Ahmad Hisham
Shairyzah Ahmad Hisham
SASyamhanin Binti Adnan
Syamhanin Binti Adnan
NNNoorlina Binti Nordin
Noorlina Binti Nordin
Introduction: Despite the established effectiveness of highly active antiretroviral therapy (HAART) in reducing HIV-related morbidity and mortality, concerns are rising regarding the emergence of metabolic syndrome (MetS). However, there is inadequate evidence regarding the incidence of MetS among adults starting first-line HAART regimens in Malaysia. Objectives: This study was conducted to determine overall incidence of MetS in HIV patients on first-line HAART regimens and to assess the association between first-line HAART and incidence of MetS at 6-month and 9-month follow-ups among studied subjects. Methodology: This was a prospective cohort study involving adult patients (≥ 18 years old) diagnosed with HIV from January 2023 till May 2023 and on first-line HAART regimen with or without integrase strand transfer inhibitor (INSTI) for at least 6 months undergoing follow-up at infectious disease (ID) clinic at a tertiary Malaysian hospital. The study subjects were screened and recruited using purposive sampling after being selectively allocated into 2 groups according to inclusion and exclusion criteria. The patients' profiles were screened via the electronic hospital information system (eHIS) using a pre-prepared data collection form. Results: A total of 210 patients were included in this study with median and interquartile range (IQR) of age was 36 (14) years. The majority of the participants were males (n= 193, 91.9%) and Malays (n= 99, 47.1%). The study results showed that overall incidence of MetS was seen the most in about one fourth of studied subjects (n= 48, 22.9%) at 9-month follow-up, whereas only 5 (2.4%) patients had MetS at 6-month follow-up. This study also found a significant association between first-line HAART and incidence of MetS at 9-month follow-up, where there was a significant increase in MetS among patients on non-INSTI regimen (29.2%) compared to those on INSTI regimen (16.3%). Conclusion: This study found that initiation of first-line HAART regimens, particularly regimens without INSTI, in individuals with HIV has been associated with an increased incidence of MetS. Thus, promoting health education and consistently monitoring patients' clinical and laboratory parameters during each visit, while implementing appropriate measures, are deemed ideal.

28 September 2022 in International journal of health sciences
Verified
Journal Article
Open access
PDF file
Ahmed Ibrahim Abdeltawwab HusseinAhmed Ibrahim Abdeltawwab Hussein
Ahmed Ibrahim Abdeltawwab Hussein
SHShairyzah Ahmad Hisham
Shairyzah Ahmad Hisham
RHRosnani Hashim
Rosnani Hashim
Objectives This study was conducted to evaluate the utilisation of antihypertensive agents, assess prescribing adherence and determine the relationship between guideline adherence indicator (GAI) and clinical outcomes among hypertensive CKD patients. Methods This was a retrospective cohort study involving newly diagnosed CKD patients undergoing follow-up between January to December 2018 at a tertiary Malaysian hospital. The study subjects were screened and recruited using simple random sampling according to inclusion and exclusion criteria. Clinical data was retrieved from the online medical record (eHis system) using a pre-prepared data collection form. Results A total of 74 patients were included in this study with mean (SD) age of 66.86 (10.86) years old. The majority were male (n= 39, 52.7%) and Malay (n= 34, 45.9%). The study results showed that CCB was the drug of choice prescribed, while the most commonly prescribed combination therapy was ACEI + beta-blocker + CCB and ACEI + CCB. The overall adherence to the guideline was moderate (mean (SD) GAI score of 76.25 (17.56) %). There was a significant difference in mean GAI score between subjects with controlled and uncontrolled BP (92.86 (11.11) vs 69.23 (14.88), P <0.05).